{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:58:17Z","timestamp":1781308697358,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011775","name":"BC Children's Hospital Foundation","doi-asserted-by":"publisher","award":["274CHI"],"award-info":[{"award-number":["274CHI"]}],"id":[{"id":"10.13039\/100011775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000046","name":"National Research Council Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002722","name":"AllerGen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-159935"],"award-info":[{"award-number":["FDN-159935"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-148484"],"award-info":[{"award-number":["PJT-148484"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["476885"],"award-info":[{"award-number":["476885"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EC1\\u2013144621"],"award-info":[{"award-number":["EC1\\u2013144621"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["AEC-85761"],"award-info":[{"award-number":["AEC-85761"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000165","name":"Sick Kids Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128342","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:36:21Z","timestamp":1773898581000},"page":"128342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort"],"prefix":"10.1016","volume":"79","author":[{"given":"Rilwan","family":"Azeez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer R.","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa C.","family":"Lotoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey L.","family":"Winsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey R.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pelchat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo J.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piush J.","family":"Mandhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E.","family":"Turvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Bolotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Bullard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Doucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona S.L.","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmaja","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan B.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128342_bb0005","unstructured":"Coronavirus disease (COVID-19): Vaccines. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-(covid-19)-vaccines."},{"key":"10.1016\/j.vaccine.2026.128342_bb0010","doi-asserted-by":"crossref","first-page":"e2035057","DOI":"10.1001\/jamanetworkopen.2020.35057","article-title":"SARS-CoV-2 Transmission From People Without COVID-19 Symptoms","volume":"4","author":"Johansson","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.vaccine.2026.128342_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.7.4.467","article-title":"Age-related decline in immunity: implications for vaccine responsiveness","volume":"7","author":"Kumar","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128342_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26185","article-title":"Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine","volume":"96","author":"Terpos","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.vaccine.2026.128342_bb0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","article-title":"Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2","volume":"27","author":"Ebinger","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128342_bb0030","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.cmi.2021.07.024","article-title":"Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study","volume":"27","author":"Buonfrate","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2026.128342_bb0035","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","article-title":"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","volume":"397","author":"Sheikh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128342_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4178\/epih.e2023091","article-title":"Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD cohort","volume":"45","author":"Azeez","year":"2023","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.vaccine.2026.128342_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2026.128342_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2026.128342_bb0055","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/jama.2021.15125","article-title":"Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273","volume":"326","author":"Steensels","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128342_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252621","article-title":"Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots","volume":"16","author":"Turgeon","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128342_bb0065","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1515\/cclm-2020-1436","article-title":"Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs","volume":"59","author":"Weisser","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.vaccine.2026.128342_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1380","article-title":"A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination","volume":"11","author":"Colwill","year":"2022","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.vaccine.2026.128342_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103831","article-title":"Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?","volume":"76","author":"Nasrallah","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2026.128342_bb0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots","volume":"74","author":"Cleveland","year":"1979","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2026.128342_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/01621459.1997.10474030","article-title":"A random-effects model for multiple characteristics with possibly missing data","volume":"92","author":"Shah","year":"1997","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2026.128342_bb0090","author":"RStudio Team - RStudio"},{"key":"10.1016\/j.vaccine.2026.128342_bb0095","article-title":"Hybrid immunity and strategies for COVID-19 vaccination","volume":"0","author":"Hui","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128342_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13690-024-01298-1","article-title":"Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between march 2021 and April 2022","volume":"82","author":"Van der Heyden","year":"2024","journal-title":"Arch Public Health"},{"key":"10.1016\/j.vaccine.2026.128342_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068258","article-title":"Investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic: a prospective national cohort study","volume":"13","author":"Thon","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2026.128342_bb0110","article-title":"Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 MRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021","volume":"26","author":"Jabal","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128342_bb0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","article-title":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19","volume":"147","author":"Cervia","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2026.128342_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.128342_bb0125","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science (1979)"},{"key":"10.1016\/j.vaccine.2026.128342_bb0130","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.2147\/IDR.S369769","article-title":"Durability of SARS-CoV-2 specific IgG antibody responses following two doses of match and mixed COVID-19 vaccines regimens in Saudi population","volume":"15","author":"Mubarak","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2026.128342_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2026.128342_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100208","article-title":"Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study","volume":"10","author":"Naaber","year":"2021","journal-title":"The Lancet Regional Health - Europe"},{"key":"10.1016\/j.vaccine.2026.128342_bb0145","doi-asserted-by":"crossref","unstructured":"Martens, B. et al. A population-based study of SARS-CoV-2 IgG antibody responses to vaccination in Manitoba. Vaccines (Basel) 12, 1095 (2024).","DOI":"10.3390\/vaccines12101095"},{"key":"10.1016\/j.vaccine.2026.128342_bb0150","first-page":"1","article-title":"Demographic and clinical factors associated with SARS-CoV-2 spike 1 antibody response among vaccinated US adults: the C4R study","volume":"15","author":"Kim","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128342_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29067","article-title":"Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers","volume":"95","author":"Ahluwalia","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2026.128342_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.amjms.2021.09.006","article-title":"Prevalence, distribution and IgG antibody levels associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among health-system and community-based employees and patients","volume":"363","author":"Kabagambe","year":"2022","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.vaccine.2026.128342_bb0165","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/infdis\/jiab127","article-title":"Sex differences in the evolution of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2","volume":"224","author":"Grzelak","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128342_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020325","article-title":"Two doses of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral response and serological conversion predictors","volume":"14","author":"Majcherek","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.vaccine.2026.128342_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/v14091966","article-title":"SARS-CoV-2 spike and nucleocapsid antibody response in vaccinated Croatian healthcare workers and infected hospitalized patients: a single center cohort study","volume":"14","author":"Brli\u0107","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128342_bb0180","article-title":"Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study","author":"Hillus","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.vaccine.2026.128342_bb0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/d41586-021-01805-2","article-title":"Mix-and-match COVID vaccines: the case is growing, but questions remain","volume":"595","author":"Lewis","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128342_bb0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(21)01420-3","article-title":"Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"398","author":"Borobia","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128342_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-10020-6","article-title":"SARS-CoV-2 spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics","volume":"12","author":"van den Hoogen","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128342_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.07.022","article-title":"COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study","volume":"42","author":"Hoeve","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128342_bb0205","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268823001279","article-title":"A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition","volume":"151","author":"Jennings","year":"2023","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2026.128342_bb0215","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fimmu.2014.00434","article-title":"The role of environmental factors in modulating immune responses in early life","volume":"5","author":"MacGillivray","year":"2014","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:53:59Z","timestamp":1781308439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":42,"alternative-id":["S0264410X26001507"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128342","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128342"}}